公开(公告)号：US20060103158A1

公开(公告)日：2006-05-18

申请号：US11289019

申请日：2005-11-29

Applicant: Robert Morrison

Inventor： Robert Morrison

IPC: B60R9/00

CPC classification number: B60P7/0892 ,  B60P7/135 ,  B60R9/00

Abstract: Described is a cargo apparatus (10) including a base (16) having at least one end (30) and at least one side (28), with the at least one end having at least one laterally inside post (20) extending therefrom, and with the at least one side having at least one laterally outside post (18) extending therefrom. At least one end bracket (24) and at least one side bracket (22) are pivotably and translatably mounted to the base, wherein the brackets each have at least one support leg (38, 44) with a mounting end (42, 48). The mounting end pivotably mounts to its respective post on the base between open and closed positions and also translatably mounts to its respective post between an unlocked position distal the post and a locked position proximal the post, whereby the apparatus is collapsible to a closed portable position, and is foldable to a sturdy, open position.

公开(公告)号：US20050208039A1

公开(公告)日：2005-09-22

申请号：US10776773

申请日：2004-02-10

Applicant: Aya Jakobovits ,  Robert Morrison ,  Arthur Raitano ,  Pia Challita-Eid ,  Juan Perez-Villar ,  Karen Morrison ,  Mary Faris ,  Wangmao Ge ,  Jean Gudas ,  Steven Kanner

Inventor： Aya Jakobovits ,  Robert Morrison ,  Arthur Raitano ,  Pia Challita-Eid ,  Juan Perez-Villar ,  Karen Morrison ,  Mary Faris ,  Wangmao Ge ,  Jean Gudas ,  Steven Kanner

IPC: A61K38/00 ,  A61K38/08 ,  A61K38/10 ,  A61K39/395 ,  C07K7/06 ,  C07K7/08 ,  C07K14/47

CPC classification number: C07K16/18 ,  A61K38/00 ,  A61K47/646 ,  A61K47/6813 ,  A61K51/1093 ,  C07K14/47 ,  C07K16/30 ,  C07K16/3038 ,  C07K2317/54 ,  C07K2317/55 ,  C07K2317/622 ,  G01N33/57484 ,  Y10T436/25

Abstract: A novel gene (designated 158P1D7) and its encoded protein are described. While 158P1D7 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including set forth in Table 1. Consequently, 158P1D7 provides a diagnostic and/or therapeutic target for cancers. The 158P1D7 gene or fragment thereof, or its encoded protein or a fragment thereof, can be used to elicit an immune response.

公开(公告)号：US20050191312A1

公开(公告)日：2005-09-01

申请号：US10994106

申请日：2004-11-19

Applicant: Arthur Raitano ,  Aya Jakobovits ,  Pia Challita-Eid ,  Steven Kanner ,  Wangmao Ge ,  Juan Perez-Villar ,  Robert Morrison

Inventor： Arthur Raitano ,  Aya Jakobovits ,  Pia Challita-Eid ,  Steven Kanner ,  Wangmao Ge ,  Juan Perez-Villar ,  Robert Morrison

IPC: A01K67/00 ,  A61K38/17 ,  A61K39/00 ,  A61K39/395 ,  A61K48/00 ,  C07K14/82 ,  C12N5/06

CPC classification number: C07K14/4748 ,  A61K39/00 ,  C07K16/30

Abstract: A novel gene 158P3D2 and its encoded protein, and variants thereof, are described wherein 158P3D2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 158P3D2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 158P3D2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 158P3D2 can be used in active or passive immunization.

Abstract translation: 描述了一种新型基因158P3D2及其编码的蛋白及其变体，其中158P3D2在正常成人组织中表现出组织特异性表达，并且在表I中列出的癌症中异常表达。因此，158P3D2提供诊断，预后，预防和/ 或癌症的治疗靶标。 158P3D2基因或其片段或其编码的蛋白质或其变体或其片段可用于引发体液或细胞免疫应答; 与158P3D2反应的抗体或T细胞可用于主动或被动免疫。

公开(公告)号：USD806606S1

公开(公告)日：2018-01-02

申请号：US29553569

申请日：2016-02-03

Applicant: Robert Morrison

Designer： Robert Morrison

公开(公告)号：US07988809B2

公开(公告)日：2011-08-02

申请号：US11471078

申请日：2006-06-20

Applicant: Lance Smith ,  Yen-Seine Wang ,  Robert Morrison ,  Clark Smith

Inventor： Lance Smith ,  Yen-Seine Wang ,  Robert Morrison ,  Clark Smith

IPC: B29C65/00 ,  B32B37/00 ,  B32B3/00 ,  B32B3/12 ,  C09J5/02 ,  C09J4/00 ,  C09J101/00 ,  C09J201/00 ,  B64C1/00

CPC classification number: B32B3/12 ,  B32B7/12 ,  B32B37/12 ,  B32B37/146 ,  B32B2305/076 ,  B32B2605/18 ,  B64C1/18 ,  E04C2/365 ,  Y10T428/236 ,  Y10T428/24149 ,  Y10T428/24165

Abstract: Aircraft floor and interior panels where core-skin bonding is improved between honeycomb and composite face sheets (skins) by applying a polyamide and/or rubber-containing adhesive to the edge of the honeycomb prior to bonding. Edge coating of the honeycomb allows one to reduce panel weight without reducing the performance parameters that are required for different types of aircraft floor and interior panels.

Abstract translation: 飞机地板和内部面板通过在粘合之前将蜂窝和复合面板（表皮）施加到蜂窝状边缘上而改善蜂窝和复合面板之间的核心 - 皮肤粘结。 蜂窝的边缘涂层可以降低面板重量，而不会降低不同类型的飞机地板和内部面板所需的性能参数。

公开(公告)号：US20110056330A1

公开(公告)日：2011-03-10

申请号：US12991211

申请日：2009-03-23

Applicant: Vladimir Muhlbach ,  Robert Morrison

Inventor： Vladimir Muhlbach ,  Robert Morrison

IPC: F16H47/06

CPC classification number: F16H3/093 ,  F16H2003/0935 ,  Y10T74/19009 ,  Y10T74/19233

Abstract: A multi-gear powershift transmission for a working machine, in particular a forklift truck, which has a driveshaft (2) driven by a torque converter (1) such that, by way of fixed wheels (8, 13, 18, 23), loose wheels (10, 15, 20, 27) and shift clutches (4, 9, 19) arranged on countershafts (7, 12, 22) in a first transmission, at least two forward gears and two reverse gears can be engaged. The powershift transmission can be supplemented with a further countershaft (24) having a fixed wheel (25), a clutch (26) and a loose wheel (27) in order to produce a second powershift transmission in which three gears in the forward driving direction and three gears in the reverse driving direction are engageable.

Abstract translation: 一种用于工作机械，特别是叉车的多档动力换挡变速器，其具有由变矩器（1）驱动的驱动轴（2），以便通过固定轮（8,13,18,23）， 在第一变速器中布置有中间轴（7,12,22）的松动轮（10,15,20,27）和布置在中间轴（7,12,22）上的换档离合器（4,9,19）可以接合至少两个前进档和两个倒档。 动力换挡变速器可以补充有具有固定轮（25），离合器（26）和松动轮（27）的另外的中间轴（24），以便产生第二动力换挡变速器，其中在正向驱动方向上的三个齿轮 并且反向驱动方向上的三个齿轮是可接合的。

公开(公告)号：US07507461B2

公开(公告)日：2009-03-24

申请号：US10932510

申请日：2004-09-01

Applicant: Yen-Seine Wang ,  Robert Morrison ,  Clark Smith

Inventor： Yen-Seine Wang ,  Robert Morrison ,  Clark Smith

IPC: B32B3/12 ,  B32B3/20 ,  B32B23/02 ,  B32B27/00 ,  C09J5/02 ,  C09J163/00 ,  B41J2/16

CPC classification number: B32B5/02 ,  B32B3/12 ,  B32B7/12 ,  B32B2250/03 ,  B32B2250/40 ,  B32B2255/26 ,  B32B2260/023 ,  B32B2260/046 ,  B32B2307/50 ,  B32B2307/54 ,  B32B2307/718 ,  B32B2419/00 ,  B32B2605/18 ,  E04C2/365 ,  Y10T428/236 ,  Y10T428/24149 ,  Y10T428/24744 ,  Y10T428/24777

Abstract: Core-skin bonding is improved between honeycomb and composite face sheets by applying a nylon-based (polyamide) adhesive to the edge of the honeycomb prior to bonding. Edge coating of honeycomb with polyamide adhesives is useful in further increasing the bond strength between honeycomb and prepreg face sheets, especially when the matrix resin of the prepreg is designed to adhere the prepreg to the honeycomb.

Abstract translation: 在粘合之前，通过将尼龙（聚酰胺）粘合剂施加到蜂窝状的边缘上，蜂窝和复合面板之间的核心 - 皮肤粘合得到改善。 具有聚酰胺粘合剂的蜂窝状边缘涂层有助于进一步提高蜂窝状和预浸料面板之间的粘结强度，特别是当预浸料坯的基体树脂设计成将预浸料坯粘附到蜂窝体上时。

公开(公告)号：US20070048283A1

公开(公告)日：2007-03-01

申请号：US11154298

申请日：2005-06-15

Applicant: Aya Jakobovits ,  Pia Challita-Eid ,  Mary Faris ,  Wangmao Ge ,  Rene Hubert ,  Karen Morrison ,  Robert Morrison ,  Arthur Raitano ,  Daniel Afar

Inventor： Aya Jakobovits ,  Pia Challita-Eid ,  Mary Faris ,  Wangmao Ge ,  Rene Hubert ,  Karen Morrison ,  Robert Morrison ,  Arthur Raitano ,  Daniel Afar

IPC: A61K39/395 ,  A61K48/00

CPC classification number: C07K14/47 ,  A61K47/646 ,  A61K47/6851 ,  A61K47/6901 ,  A61K51/1045

Abstract: Novel genes designated and set forth in FIG. 2 and their respective encoded proteins, and variants thereof, are described wherein a gene of the invention exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers such as those listed in Table I. Consequently, of gene products of a gene of FIG. 2 provide diagnostic, prognostic, prophylactic and/or therapeutic targets for cancer. A gene of FIG. 2 or fragment thereof, its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with a gene product of FIG. 2 can be used in active or passive immunization.

公开(公告)号：US20060294104A1

公开(公告)日：2006-12-28

申请号：US11188143

申请日：2005-07-22

Applicant: Robert Morrison ,  Paul D'Eon

Inventor： Robert Morrison ,  Paul D'Eon

IPC: G06F17/30

CPC classification number: G06F16/21

Abstract: A data-retrieval system maintains a database of records with which it associates respective security keys. It uses those security keys as a basis for deciding whether to grant access to the records. It additionally maintains organizational information that lists relationships among positions within an organization. When a requestor requests access to a record in the database, the system associates zero or more positions with the requestor, typically by determining which position or positions within the organization the requestor occupies. It additionally determines which, if any, other positions within the organization bear a predetermined relationship to any such occupied position, and it assembles a key list that includes keys that it has associated with all such positions. The way in which the system determines whether to grant the requestor access to the record is to determine whether the security key associated with that record matches any key in the key list.

Abstract translation: 数据检索系统维护与之相关联的各个安全密钥的记录数据库。 它使用这些安全密钥作为决定是否授予访问记录的依据。 它还维护组织信息，列出组织中职位之间的关系。 当请求者请求访问数据库中的记录时，系统通常通过确定请求者占据的组织中的哪个位置或位置将零个或多个位置与请求者相关联。 它另外确定组织内的其他位置（如果有的话）与任何这样的占用位置具有预定的关系，并且组合包括与所有这样的位置相关联的键的键列表。 系统确定是否授予请求者访问记录的方式是确定与该记录相关联的安全密钥是否与密钥列表中的任何密钥相匹配。

公开(公告)号：US20060275211A1

公开(公告)日：2006-12-07

申请号：US11396178

申请日：2006-03-31

Applicant: Aya Jakobovits ,  Steven Kanner ,  Pia Challita-Eid ,  Juan Perez-Villar ,  Daulet Satpaev ,  Arthur Raitano ,  Robert Morrison ,  Karen Morrison ,  Xiao-Chi Jia ,  Jean Gudas

Inventor： Aya Jakobovits ,  Steven Kanner ,  Pia Challita-Eid ,  Juan Perez-Villar ,  Daulet Satpaev ,  Arthur Raitano ,  Robert Morrison ,  Karen Morrison ,  Xiao-Chi Jia ,  Jean Gudas

IPC: A61K51/00 ,  C12Q1/68 ,  G01N33/574 ,  C07H21/04 ,  C12P21/06 ,  A61K39/395 ,  C07K14/82 ,  C07K16/30 ,  C07K16/46

CPC classification number: C07K16/30 ,  A61K31/7088 ,  A61K39/00 ,  A61K51/1045 ,  A61K2039/505 ,  C07K14/47 ,  C07K16/18 ,  C07K16/3023 ,  C07K16/303 ,  C07K16/3038 ,  C07K16/3046 ,  C07K16/3061 ,  C07K16/3069 ,  C07K16/40 ,  C07K2317/20 ,  C07K2317/33 ,  C07K2317/34 ,  C07K2317/54 ,  C07K2317/55 ,  C07K2317/73 ,  C07K2317/76 ,  C07K2317/77 ,  C07K2319/30 ,  C12N9/16 ,  C12Q1/6886 ,  C12Q2600/158 ,  G01N33/57492 ,  Y02A50/466

Abstract: Antibodies and molecules derived therefrom that bind to 161P2F10B protein and variants thereof, are described wherein 161P2F10B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 161P2F10B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 161P2F10B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 161P2F10B can be used in active or passive immunization.